multiple sclerosis

November 11, 2024

Posted by Communication - IIS Aragón el November 11, 2024

A new drug promises to curb multiple sclerosis, Parkinson's and Alzheimer's

Researchers at University College London and Loyola University have developed a modified compound of cyclosporin A that blocks cyclophilin D in the brain, offering a new avenue for treating neurodegenerative diseases. Early animal studies show promising results.

28 February, 2024

Posted by Communication - IIS Aragón el 28 February, 2024

Researchers from the IIS Aragón have participated in a study on the effectiveness of dry needling for improving gait in patients with multiple sclerosis

The iHealthy research group participates in a study that seeks to evaluate the effectiveness of the “dry needling” technique in improving gait disorders in patients with multiple sclerosis.

8 February, 2024

Posted by Communication - IIS Aragón el 8 February, 2024

Why women are more at risk of lupus, arthritis or multiple sclerosis

The statistics are clear. Women suffer more autoimmune diseases than men. A study published in the journal Cell points to the silencing of one of the X chromosomes as a factor that, although necessary for the proper production of proteins, seems to be behind these disorders.